People: Protalix Biotherapeutics Inc (PLX.TA)

PLX.TA on Tel Aviv Stock Exchange

914.20
20 Oct 2014
Price Change (% chg)

-31.30₪ (-3.30%)
Prev Close
948.80₪
Open
950.00₪
Day's High
964.00₪
Day's Low
900.00₪
Volume
334,687
Avg. Vol
227,963
52-wk High
1,845.00₪
52-wk Low
819.00₪

Search Stocks

Bronfeld, Zeev 

Brief Biography

Mr. Zeev Bronfeld has been appointed Protalix Biotherapeutics, Inc. effective July 24, 2014. Until this date, he served as Independent Interim Chairman of the Board at the Company from March 9, 2010. Prior to that, Mr. Bronfeld served as Director at the Company from December 31, 2006. Mr. Bronfeld is an experienced businessman who is involved in a number of biotechnology companies. He is a co-founder of Biocell Ltd. (TASE:BCEL), an Israeli publicly traded holding company specializing in biotechnology companies and has served as its Chief Executive Officer since 1986. Mr. Bronfeld currently serves as a director of Biocell Ltd., Biomedix Incubator Ltd. (TASE: BMDX), D.N.A. Biomedical Solutions Ltd. (TASE:DNA), and Gefen Biomed Investments Ltd. (TASE:GEFEN), all of which are public companies traded on the TASE. Mr. Bronfeld is also a director of each of the following privately-held companies: EcoCycle Israel Ltd., Contipi Ltd., L.N. Innovative Technologies, A.T.I Ashkelon Industries Information Technologies Ltd., The Trendlines Group, MOFET B'Yehuda - Industrial Research & Development in Judea Ltd., Incubator for Management of Technological Entrepreneurship Misgav Ltd., A.Y.M.B. Holdings and Investments Ltd., TransBiodiesel Ltd., Entera Bio Ltd., Incubator for Management of Technological Entrepreneurship Misgav Ltd., M.B.R.T. Development and Investments Ltd., Macrocure Ltd., Nanothera Ltd., Spearhead Investment Ltd., Stimatix G.I. Ltd. and Apifix Ltd. Mr. Bronfeld received a B.A. in Economics from the Hebrew University in 1975.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Shlomo Yanai

--

David Aviezer

3,230,140

Yossi Maimon

1,389,600

Tzvi Palash

669,029

Yoseph Shaaltiel

1,594,580

Einat Almon

1,436,370
As Of 30 Dec 2012
Search Stocks